What does Madrigal Pharmaceuticals, Inc. do?
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is…
What is Madrigal Pharmaceuticals, Inc.'s P/E and P/B ratio?
Madrigal Pharmaceuticals, Inc. has a P/E ratio of -35.3 and a P/B ratio of 20.00.
What is Madrigal Pharmaceuticals, Inc.'s debt-to-equity ratio?
Madrigal Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.66.
How much does Madrigal Pharmaceuticals, Inc. owe compared with what it owns?
Madrigal Pharmaceuticals, Inc. owes $0.58 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Madrigal Pharmaceuticals, Inc.'s Positivity rank?
Madrigal Pharmaceuticals, Inc. is ranked #6,086 of 6,774 companies globally and #3,445 of 4,000 in United States on PositoAI, with a Positivity Score of 9,849.
Does Madrigal Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Madrigal Pharmaceuticals, Inc..
Where can I read the latest news about Madrigal Pharmaceuticals, Inc.?
Recent headlines about Madrigal Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Madrigal Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Madrigal Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.